ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2107

Social Determinants of Health and Clinical Outcomes in Rheumatoid Arthritis: A Single Center Study

Nicholas Wiemer1, Yue Yin2 and Tarun Sharma1, 1Allegheny Health Network, Pittsburgh, PA, 2Allegheny Health Network Singer Research Institute, Pittsburgh, PA

Meeting: ACR Convergence 2023

Keywords: depression, Outcome measures, rheumatoid arthritis, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic and potentially debilitating disease.Social determinants, including smoking and depression, have been shown to be linked to worse clinical outcomes in RA.In this study, we aim to determine the prevalence of eleven social determinants of health (SDOH) in the RA cohort at our health system.

Methods: A retrospective review of patients seen as part of the RA Care Pathway, a well-defined cohort of adult patients with RA at AHN Rheumatology, was performed.Demographics, serologies, medications, and SDOH metrics were captured and validated via chart review. Patients were included if they had a RA Clinical Disease Activity Index (CDAI) and at least 3 social determinants completed within 6 months of each other. Patients were then examined in two groups, CDAI ≥10 (moderate-severe RA) and CDAI < 10 (remission and low disease activity) to assess any differential impact of SDOH.

Results: A total of 137 patients were reviewed, of which 50 met inclusion criteria. Average age was 65.5 years, 74% were female, and 66% were Caucasian. Mean CDAI was 9.64 with 36% patients in the moderate-severe CDAI group. Several SDOH metrics were unfavorably distributed in the CDAI ≥10 compared to < 10 group, including smoking (55.56% vs 31.25%), housing instability (11.11% vs 0%), depression (16.67% vs 6.25% with mean PHQ9 scores 18 vs 0.88, respectively), and low health literacy (11.11% vs 46.88%).Smoking patients were more likely to have high disease activity (OR 2.25, 95% CI [1.03, 4.89], p=0.04).

Conclusion: Our data reveals that RA patients with moderate-high disease activity are more likely to have high risk social determinants of health including high likelihood of smoking, housing instability, and depression. A team-based care approach has been implemented at AHN Rheumatology. Our next steps are to better capture SDOH and determine the impact of SDOH interventions on clinical outcomes in RA.

Supporting image 1

SDoH: social determinants of health, CDAI: clinical disease activity index, PHQ: patient health questionnaire

Supporting image 2

PHQ: patient health questionnaire


Disclosures: N. Wiemer: None; Y. Yin: None; T. Sharma: None.

To cite this abstract in AMA style:

Wiemer N, Yin Y, Sharma T. Social Determinants of Health and Clinical Outcomes in Rheumatoid Arthritis: A Single Center Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/social-determinants-of-health-and-clinical-outcomes-in-rheumatoid-arthritis-a-single-center-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/social-determinants-of-health-and-clinical-outcomes-in-rheumatoid-arthritis-a-single-center-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology